增强内源性腺苷信号可提升大鼠神经损伤后脊髓电刺激的镇痛效果
该研究在大鼠胫骨保留神经损伤(SNI-t)模型中探索腺苷A1和A3受体在脊髓电刺激(SCS)抑制脊髓伤害性传递中的作用,并评估腺苷脱氨酶抑制剂dCF能否增强SCS镇痛。电生理显示A1R和A3R拮抗剂减弱SCS对C纤维诱发电位(C-LFP)的抑制,而dCF增强该抑制;行为学中鞘内dCF也增强SCS对机械超敏的抑制。提示抑制腺苷脱氨酶可能作为增强SCS镇痛的辅助药物治疗。
要点
- 脊髓A1R和A3R信号对脊髓伤害性传递有紧张性抑制并参与SCS镇痛。
- dCF增强SCS对C-LFP的抑制并改善SNI-t大鼠机械超敏。
- 腺苷脱氨酶抑制可能作为增强SCS镇痛的辅助策略。
核心结论
- 脊髓A1R和A3R信号既发挥紧张性抑制,也参与神经损伤后SCS对脊髓伤害性传递的抑制。
- 抑制腺苷脱氨酶可能是一种增强SCS诱导镇痛的新型辅助药物治疗。
研究设计与样本
- 研究使用大鼠胫骨保留神经损伤(SNI-t)模型。
- 采用RNAscope和免疫印迹检查adora1和adora3表达分布及A1R、A3R蛋白水平。
- 采用电生理记录评估腺苷受体拮抗剂、病毒介导adora3敲低和dCF对SCS抑制C-LFP的影响。
- 行为学实验评估鞘内dCF对SCS抑制机械超敏的影响。
主要发现
- Adora1主要表达于神经元,而adora3在小胶质细胞中高表达。
- 脊髓应用A1R拮抗剂DPCPX(50 μM,100 μl)和A3R拮抗剂MRS1523(200 nM,100 μl)增加SNI-t大鼠C-LFP(DPCPX: 1.39 [0.18] vs vehicle: 0.98 [0.05], P=0.046; MRS1523: 1.21 [0.07] vs vehicle: 0.91 [0.03], P=0.002)。
- 两种拮抗剂均阻断SCS对C-LFP的抑制。
- dCF(0.1 mM)增强SCS诱导的C-LFP抑制(dCF: 0.60 [0.04] vs vehicle: 0.85 [0.02], P<0.001)。
- 鞘内dCF(100 nmol 15 μl-1)增强SCS对SNI-t大鼠机械超敏的抑制。
临床怎么用
- 针对腺苷脱氨酶的药物干预可能作为SCS镇痛的辅助治疗,但需临床研究验证。
局限性
- 研究为大鼠SNI-t模型,结果向临床转化需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The mechanisms for spinal cord stimulation (SCS) to alleviate chronic pain are only partially known. We aimed to elucidate the roles of adenosine A1 and A3 receptors (A1R, A3R) in the inhibition of spinal nociceptive transmission by SCS, and further explored whether 2'-deoxycoformycin (dCF), an inhibitor of adenosine deaminase, can potentiate SCS-induced analgesia. METHODS: We used RNAscope and immunoblotting to examine the distributions of adora1 and adora3 expression, and levels of A1R and A3R proteins in the spinal cord of rats after tibial-spared nerve injury (SNI-t). Electrophysiology recording was conducted to examine how adenosine receptor antagonists, virus-mediated adora3 knockdown, and dCF affect SCS-induced inhibition of C-fibre-evoked spinal local field potential (C-LFP). RESULTS: Adora1 was predominantly expressed in neurones, whereas adora3 is highly expressed in microglial cells in the rat spinal cord. Spinal application of antagonists (100 μl) of A1R (8-cyclopentyl-1,3-dipropylxanthine [DPCPX], 50 μM) and A3R (MRS1523, 200 nM) augmented C-LFP in SNI-t rats (DPCPX: 1.39 [0.18] vs vehicle: 0.98 [0.05], P=0.046; MRS1523: 1.21 [0.07] vs vehicle: 0.91 [0.03], P=0.002). Both drugs also blocked inhibition of C-LFP by SCS. Conversely, dCF (0.1 mM) enhanced SCS-induced C-LFP inhibition (dCF: 0.60 [0.04] vs vehicle: 0.85 [0.02], P<0.001). In the behaviour study, dCF (100 nmol 15 μl-1, intrathecal) also enhanced inhibition of mechanical hypersensitivity by SCS in SNI-t rats. CONCLUSIONS: Spinal A1R and A3R signalling can exert tonic suppression and also contribute to SCS-induced inhibition of spinal nociceptive transmission after nerve injury. Inhibition of adenosine deaminase may represent a novel adjuvant pharmacotherapy to enhance SCS-induced analgesia.
引用
- Cui X, Liu J, Uniyal A, et al. Enhancing spinal cord stimulation-induced pain inhibition by augmenting endogenous adenosine signalling after nerve injury in rats. Br J Anaesth. 2024. PMID: 38310069. doi:10.1016/j.bja.2024.01.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。